Views provided by UsageCounts
AbstractLeukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti‐tuberculosis drugs is very rarely seen. This report describes the case of a 12‐year‐old girl who developed LCV with rifampicin and ethambutol while undergoing anti‐tuberculosis treatment due to extensive pulmonary involvement.
leukocytoclastic vasculitis, Biopsy, Antitubercular Agents, ethambutol, rifampicin, anti-tuberculosis drug, Humans, Vasculitis, Leukocytoclastic, Cutaneous, Female, Child, Tuberculosis, Pulmonary, Skin
leukocytoclastic vasculitis, Biopsy, Antitubercular Agents, ethambutol, rifampicin, anti-tuberculosis drug, Humans, Vasculitis, Leukocytoclastic, Cutaneous, Female, Child, Tuberculosis, Pulmonary, Skin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 6 |

Views provided by UsageCounts